These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22817722)

  • 1. Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles.
    Ward NA; Hirst S; Williams J; Findlay JB
    Biochem Soc Trans; 2012 Aug; 40(4):717-20. PubMed ID: 22817722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in melanocortin-4 receptor and human obesity.
    Tao YX
    Prog Mol Biol Transl Sci; 2009; 88():173-204. PubMed ID: 20374728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone.
    Granell S; Mohammad S; Ramanagoudr-Bhojappa R; Baldini G
    Mol Endocrinol; 2010 Sep; 24(9):1805-21. PubMed ID: 20631012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through.
    Brumm H; Mühlhaus J; Bolze F; Scherag S; Hinney A; Hebebrand J; Wiegand S; Klingenspor M; Grüters A; Krude H; Biebermann H
    Obesity (Silver Spring); 2012 May; 20(5):1074-81. PubMed ID: 21738238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 receptor mutants.
    Meimaridou E; Gooljar SB; Ramnarace N; Anthonypillai L; Clark AJ; Chapple JP
    Mol Endocrinol; 2011 Sep; 25(9):1650-60. PubMed ID: 21719532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity.
    Huang H; Wang W; Tao YX
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt A):2496-2507. PubMed ID: 28284973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.
    Wang XH; Wang HM; Zhao BL; Yu P; Fan ZC
    J Mol Endocrinol; 2014 Aug; 53(1):17-29. PubMed ID: 24780838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy.
    Alfieri A; Pasanisi F; Salzano S; Esposito L; Martone D; Tafuri D; Daniele A; Contaldo F; Sacchetti L; Zagari A; Buono P
    Gene; 2010 Jun; 457(1-2):35-41. PubMed ID: 20214954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity.
    Tao YX; Segaloff DL
    Endocrinology; 2003 Oct; 144(10):4544-51. PubMed ID: 12959994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
    Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
    J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.
    Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsen 5i is a Novel Potent Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants.
    Tao YX; Huang H
    Front Endocrinol (Lausanne); 2014; 5():131. PubMed ID: 25136332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients.
    Fan ZC; Tao YX
    J Cell Mol Med; 2009 Sep; 13(9B):3268-82. PubMed ID: 19298524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity.
    René P; Le Gouill C; Pogozheva ID; Lee G; Mosberg HI; Farooqi IS; Valenzano KJ; Bouvier M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):520-32. PubMed ID: 20826565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.
    Ochoa MC; Azcona C; Biebermann H; Brumm H; Razquin C; Wermter AK; Martínez JA; Hebebrand J; Hinney A; Moreno-Aliaga MJ; Marti A; Patiño A; Chueca M; Oyarzabal M; Pelach R;
    Clin Endocrinol (Oxf); 2007 May; 66(5):652-8. PubMed ID: 17492953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity.
    Tao YX
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):1-14. PubMed ID: 15975705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule agonist THIQ as a novel pharmacoperone for intracellularly retained melanocortin-4 receptor mutants.
    Huang H; Tao YX
    Int J Biol Sci; 2014; 10(8):817-24. PubMed ID: 25076858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel melanocortin 4 receptor gene mutations in severely obese children.
    Lee YS; Poh LK; Kek BL; Loke KY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):529-35. PubMed ID: 17941900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population.
    Rong R; Tao YX; Cheung BM; Xu A; Cheung GC; Lam KS
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):198-205. PubMed ID: 16886960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of transmembrane domain 3 of human melanocortin-4 receptor.
    Mo XL; Yang R; Tao YX
    J Mol Endocrinol; 2012 Dec; 49(3):221-35. PubMed ID: 23014838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.